SCHEDULE 13G 0002055074 XXXXXXXX LIVE American Depositary Shares, each representing 4,000 Ordinary Shares, no par value 02/09/2025 0001611747 Scinai Immunotherapeutics Ltd. 09073Q203 JERUSALEM BIOPARK, 2ND FLOOR Hadassah Ein Kerem Campus Jerusalem L3 00000 Rule 13d-1(c) LCK JNK 1 LLC X1 80757.00 0.00 80757.00 0.00 80757.00 N 9.5 OO Based on 3,411,983,584 ordinary shares outstanding as of September 30, 2024, as disclosed by the issuer on November 22, 2024. Scinai Immunotherapeutics Ltd. Jerusalem BioPark, 2nd Floor, Hadassah Ein Kerem Campus, Jerusalem, Israel, 0000000 LCK JNK 1 LLC The shares reported herein are directly held by LCK JNK 1 LLC. Richard J. Kertzman is the managing member of LCK JNK LLC. Accordingly, Mr. Kertzman may be deemed to indirectly beneficially own the securities of the Issuer held by LCK JNK LLC. 3105 NW 107th Avenue, Suite 103, Doral, FL 33172 U.S. Y 80,757 9.5% 80,757 0 80,757 0 Y Y Y Y Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. LCK JNK 1 LLC /s/ Richard J. Kertzman 02/24/2025